Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of Glyceryl Tridecanoate Emulsion in Healthy Men
NCT03255889Phase 1Withdrawn
- Sponsor
- National University Hospital
- Start
- Aug 2017
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, triple-blind trial in polycystic ovary syndrome (PCOS) comparing Glyceryl Tridecanoate with Placebo (2 arms). Primary endpoint: Incidence and severity of adverse events/severe events. Planned start Aug 2017; status: withdrawn.
02
Drugs
tricaprin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03255889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03255889.